Leptomeningeal metastasis from non-small cell lung cancer: survival and the impact of whole brain radiotherapy.
about
The role of EGFR-TKI for leptomeningeal metastases from non-small cell lung cancerMolecular Targeted Therapies for the Treatment of Leptomeningeal Carcinomatosis: Current Evidence and Future DirectionsDiagnosis and Treatment of Leptomeningeal Metastasis in Non-small Cell Lung CancerRecent Advancements of Treatment for Leptomeningeal CarcinomatosisManaging leptomeningeal melanoma metastases in the era of immune and targeted therapy.Concurrent Afatinib and Whole-Brain Radiotherapy in Exon 19-del-EGFR Mutant Lung Adenocarcinoma: A Case Report and Mini Review of the Literature.Leptomeningeal Carcinomatosis in Recurrent Non-Small Cell Lung Cancer: A Case Report and Review of Current Treatment Modalities.Carcinomatous meningitis in non-small cell lung cancer: Palliation with intrathecal treatment.Impact of multimodality approach for patients with leptomeningeal metastases from solid tumorsAlectinib salvages CNS relapses in ALK-positive lung cancer patients previously treated with crizotinib and ceritinib.Treatment and prognostic analysis of patients with leptomeningeal metastases from non-small cell lung cancer.Carcinomatous meningitis: Leptomeningeal metastases in solid tumorsRare cell capture technology for the diagnosis of leptomeningeal metastasis in solid tumorsIntrathecal chemotherapy as a treatment for leptomeningeal metastasis of non-small cell lung cancer: A pooled analysisRapid Response to High-Dose, Pulsatile Erlotinib in Afatinib-Refractory Leptomeningeal Carcinomatosis from Adenocarcinoma of the Lung: A Case Report.Concurrent radiotherapy and intrathecal methotrexate for treating leptomeningeal metastasis from solid tumors with adverse prognostic factors: A prospective and single-arm study.EGFR mutation status in brain metastases of non-small cell lung carcinoma.Neuro-ophthalmologic complications of neoplastic leptomeningeal disease.Central nervous system involvement in ALK-rearranged NSCLC: promising strategies to overcome crizotinib resistance.State of the art of chemotherapy for the treatment of central nervous system metastases from non-small cell lung cancer.Neoplastic Meningitis Due to Lung, Breast, and Melanoma Metastases.Sequencing brain metastases and opportunities for targeted therapies.Paradigm shift of therapeutic management of brain metastases in EGFR-mutant non-small cell lung cancer in the era of targeted therapy.Efficacy of multimodal treatment for leptomeningeal metastases in a lung cancer harboring an EGFR mutation.Retrospective analysis of survival in patients with leptomeningeal carcinomatosis from lung adenocarcinoma treated with erlotinib and gefitinib.Leptomeningeal metastasis of pulmonary large-cell neuroendocrine carcinoma: A case report and review of the literature.Leptomeningeal disease: current diagnostic and therapeutic strategies.A retrospective case series of 103 consecutive patients with leptomeningeal metastasis and breast cancer.Pulsed Erlotinib as Sole Treatment of Leptomeningeal Carcinomatosis: Can We Avoid the Use of Intrathecal Therapy?Neurological and cytological response as potential early predictors of time-to-progression and overall survival in patients with leptomeningeal carcinomatosis treated with intrathecal liposomal cytarabine: a retrospective cohort study.Leptomeningeal metastasis from solid tumors: a single center experience in Chinese patients.Commentary: Treatment Considerations for Patients With Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer Brain Metastases in the Era of Tyrosine Kinase Inhibitors.Standard-dose osimertinib for refractory leptomeningeal metastases in T790M-positive EGFR-mutant non-small cell lung cancer.Leptomeningeal metastasis from systemic cancer: Review and update on management.Leptomeningeal Carcinomatosis Associated with Gall Bladder Carcinoma: a Case Report and Review of Literature.Treatment of leptomeningeal spread of NSCLC: a continuing challenge.Patient outcomes of whole brain radiotherapy for brain metastases versus leptomeningeal metastases: A retrospective study.Whole brain radiotherapy in management of non-small-cell lung carcinoma associated leptomeningeal carcinomatosis: evaluation of prognostic factors.Chemical meningitis related to intra-CSF liposomal cytarabine.Impact of EGFR tyrosine kinase inhibitors versus chemotherapy on the development of leptomeningeal metastasis in never smokers with advanced adenocarcinoma of the lung.
P2860
Q26740529-D2A79AEE-5DC6-4FF3-8AD0-7ED9A96D9409Q26741320-5E8E680A-3896-4DAD-A543-E71D0F53C3DEQ26781690-6E3BE423-CF2D-4C76-BD1E-8F04E0063EC7Q26798009-74DA7DF0-D13F-46BA-9737-27AC350A2D7EQ30251581-A3AC2A77-24C3-4BC2-B17F-10D2D1A7FE0CQ33653615-161893E7-D23A-4471-9D0E-39580FC4DF3DQ33788680-E3A501C9-8F4B-4BAD-BDF8-AE994FF2DF88Q33841560-680B9499-81FB-4158-B706-DD31C75FDA5EQ34029965-B69BC93B-6596-497F-91DF-EF84A27F348CQ35007620-A1E4B430-6A91-477D-9D40-45B10ACA850AQ35879370-F4BDF28C-0D24-4282-A67A-E7A6725B623EQ36851197-CACA4347-A79F-4AA1-9F54-A69052E04A48Q36870131-99D85814-632A-4E66-B549-F6B7CB505258Q37107954-2E5AF9E8-3F4D-4AA7-96D2-7F674CA73C21Q37355963-011214C3-9AE4-416F-8CAF-FB296FA1C25AQ37394649-1AB93E6E-01A9-45F5-8FE9-33B7DFB53944Q38053963-1179DFFC-613C-4A1B-AB98-E83098861C63Q38155430-E4EDFB55-5B77-4067-917D-E099FB6CCED6Q38816270-401551DB-F31E-45E2-A6F7-6F1106B1AE83Q38985340-07E2AB8C-6AC7-4203-A676-59F5EED21FDBQ39126735-70C68C90-349C-4736-9FFA-72CF31CD64FBQ39177404-CF194E6B-A3E3-4DA0-97C7-103A7FD3296AQ39337110-3F99B5DC-C700-4B95-BF6E-A8E22D67ACA4Q39556310-9A38BFC2-F145-4D80-A83C-4FFDE6FCB06BQ40381138-DF2A9CD6-4AEE-4195-B1FD-C95698542355Q41701940-0FE1C339-F2EC-4ABF-9158-A4CDDC3BA39DQ42700664-384F6A47-C7CC-41D1-9388-6E9A7D24B814Q43651159-ABFB386A-4693-462D-A3AC-5D435B97167AQ44434925-9C16A0BC-6C06-4DD0-A06E-3746108F370CQ44502804-D328EFA8-A75F-4AAD-BCA0-627F5A3EE606Q45835927-886AAA82-0189-4DBE-BA0F-C2D180D99AB6Q46108334-F69DD9D0-3F0C-4E30-9A0C-DBC36AE77871Q47390697-B2D328CC-1E27-4E4F-A342-543240CE47C5Q47428678-F8D44250-49D6-477D-8993-BE57136C823BQ48341674-4C636E5E-EBD1-4507-8AD7-3BF3730E251AQ48427334-A68738FA-921E-43AD-A842-A2D2A6330518Q48517377-1EC9478B-E217-4B14-8AD4-88B13F5313B3Q48675213-46054900-A808-4DC2-A417-157BE3EE969EQ50066702-6A11F3C9-5459-4A59-AE88-12D8EB9AE0D1Q50853655-C9A9772C-7573-450E-9D60-326E6114590B
P2860
Leptomeningeal metastasis from non-small cell lung cancer: survival and the impact of whole brain radiotherapy.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Leptomeningeal metastasis from ...... t of whole brain radiotherapy.
@en
Leptomeningeal metastasis from ...... t of whole brain radiotherapy.
@nl
type
label
Leptomeningeal metastasis from ...... t of whole brain radiotherapy.
@en
Leptomeningeal metastasis from ...... t of whole brain radiotherapy.
@nl
prefLabel
Leptomeningeal metastasis from ...... t of whole brain radiotherapy.
@en
Leptomeningeal metastasis from ...... t of whole brain radiotherapy.
@nl
P2093
P50
P1476
Leptomeningeal metastasis from ...... t of whole brain radiotherapy.
@en
P2093
Hector R Perez
Jennifer L Clarke
Katherine S Panageas
Olga Rosenvald Szenberg
Patrick G Morris
Timothy A Chan
P304
P356
10.1097/JTO.0B013E3182398E4F
P577
2012-02-01T00:00:00Z